Scientific Park of Barcelona. Picture published with permision of Chemotargets
is a small biotech company located in Barcelona (www.chemotargets.com). It was founded in 2006 by Dr. Jordi Mestres as a spin-off company of the IMIM Hospital del Mar Institute of Medical Research (www.imim.cat). The company is the developer of the current state-of-the-art software for predictive pharmacology and safety of small molecules, CT-link. The new release includes a platform-independent Graphical User Interface to navigate across pharmacology and safety data in a highly interactive and integrative manner. Its current headquarters are located in the Scientific Park of Barcelona.